.
BioEnterprise

Abeona Therapeutics Closes $92 Million Public Offering

Abeona Therapeutics, a Cleveland developer of therapies for rare genetic diseases, closed a $92 million public stock offering. Funds will be used for working capital and corporate purposes, including development and manufacturing of its product candidates.

Read More  >
Hello. Add your message here.